Onderzoeker
Guido Vanham
- Trefwoorden:Geneeskunde
- Disciplines:Translationele wetenschappen, Klinische wetenschappen, Basiswetenschappen
Affiliaties
- Pathologische Biochemie en Fysiologie (Departement)
Lid
Vanaf1 okt 2008 → 30 sep 2011
Publicaties
1 - 10 van 10
- The role of natural killer cells in functional cure strategies for human immunodeficiency virus type 1 infection(2023)
Auteurs: Thessa Laeremans, Joeri L Aerts, Sabine Allard, Guido Vanham
Aantal pagina's: 192 - Efficient Induction of Antigen-Specific CD8+ T-Cell Responses by Cationic Peptide-Based mRNA Nanoparticles(2022)
Auteurs: Sigrid D'haese, Sabine den Roover, Guido Vanham, Joeri L Aerts
- Cytotoxic CD8+ T Cells Expressing CXCR5 Are Detectable in HIV-1 Elite Controllers After Prolonged In Vitro Peptide Stimulation(2021)
Auteurs: Philipp Adams, Gilles Iserentant, Jean-Yves Servais, Linos Vandekerckhove, Guido Vanham, Carole Seguin-Devaux
- Off the beaten path(2021)
Auteurs: Sigrid D'haese, Céline Lacroix, Felipe Garcia, Montserrat Plana, Simona Ruta, Guido Vanham, Bernard Verrier, Joeri L Aerts
Pagina's: 1016-1033 - COVID-19(2021)
Auteurs: Wim Van Damme, Ritwik Dahake, Remco van de Pas, Guido Vanham, Yibeltal Assefa
- The COVID-19 pandemic diverse contexts; different epidemics-how and why?(2020)
Auteurs: Wim Van Damme, Ritwik Dahake, Alexandre Delamou, Brecht Ingelbeen, Edwin Wouters, Guido Vanham, Remco van de Pas, Jean-Paul Dossou, Seye Abimbola, Stefaan Van der Borght, et al.
Pagina's: 1-16 - Rapid viral rebound after analytical treatment interruption in patients with very small HIV reservoir and minimal on-going viral transcription(2020)
Auteurs: Pieter Pannus, Sofie L. Rutsaert, Stéphane De Wit, Sabine Allard, Guido Vanham, Basiel Cole, Coca Nescoi, Joeri L Aerts, Ward De Spiegelaere, Achilleas Tsoumanis, et al.
- Therapeutic Vaccine in Chronically HIV-1-Infected Patients(2019)
Auteurs: Wesley de Jong, Lorna Leal, Jozefien Buyze, Pieter Pannus, Alberto C Guardo, Maria Salgado, Beatriz Mothe, Jose Molto, Sara Moron-Lopez, Cristina Gálvez, et al.
- iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy(2019)
Auteurs: Wesley de Jong, Joeri L Aerts, Sabine Allard, Christian Brander, Jozefien Buyze, Eric Florence, Eric van Gorp, Guido Vanham, Lorna Leal, Beatriz Mothe, et al.
- Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection(2018)
Auteurs: Lorna Leal, Alberto C Guardo, Sara Morón-López, Maria Salgado, Beatriz Mothe, Carlo Heirman, Pieter Pannus, Guido Vanham, Henk-Jan van den Ham, Rob A. Gruters, et al.
Pagina's: 2533-2545